Coronavirus Information and Resources
The coronavirus outbreak that has been declared a pandemic by the World Health Organization is affecting people throughout the United States and around the world – and cancer patients, survivors, and their families have been hit particularly hard.
Challenges and disruptions caused by the coronavirus at doctors’ offices, hospitals, and other care locations can make ongoing cancer treatments, participation in clinical trials, and even routine follow-ups difficult. It is critical, therefore, that cancer patients undergoing treatment or follow-up care contact and coordinate with their health care providers. Cancer clinical trial participants should call their research teams for guidance.
The National Cancer Institute (NCI) states that because there is no vaccine against the virus, “the best way to prevent illness is to avoid exposure to the virus.” In addition to washing hands with soap and water for at least 20 seconds particularly after going to the bathroom, sneezing, blowing your nose, and before and after contact with other people, cancer patients should avoid large crowds, minimize person-to-person contact, and get vaccinated for the flu.
A new consortium is gathering information on how cancer patients fare with COVID-19. A wide range of cancer centers, from large NCI-designated Comprehensive Cancer Centers to small community practices, are participating in the effort, which was chronicled in a recent post on Cancer Research Catalyst, the AACR’s blog.
The Alliance for Aging Research, a nonprofit organization devoted to speeding the pace of scientific discoveries related to aging and health, created a webpage dedicated to questions and answers on COVID-19 for older people and those with chronic health conditions. And here is a news roundup on COVID-19 from the National Foundation for Infectious Diseases, a nonprofit organization “dedicated to educating the public and healthcare professionals about the burden, causes, prevention, diagnosis, and treatment of infectious diseases across the lifespan.
The elderly, severely obese individuals, those who are immunocompromised, and anyone with serious underlying medical conditions including cancer, chronic lung disease, and heart disease are at higher risk of severe illness from COVID-19, according to the U.S. Centers for Disease Control and Prevention (CDC).
The U.S. Food and Drug Administration (FDA) has provided the institutions and investigators conducting clinical trials guidance during the COVID-19 pandemic. The nine-page PDF guidance (comprising “nonbinding recommendations”) can be accessed here: https://www.fda.gov/media/136238/download.
Learn more about this FDA guidance and clinical trials information from the NCI in this article from Cancer Today, a magazine for cancer patients, survivors, and their family members and friends published by the American Association for Cancer Research (AACR).
Cancer Today reports that some cancer centers are utilizing their in-house molecular laboratories to test some cancer patients for the novel coronavirus. Ready “Testing Cancer Patients for the Coronavirus” on the magazine’s website.
Cancer Today magazine has ongoing coverage of COVID-19 and its impact on cancer patients, including the magazine’s weekly roundup of cancer news. An article on how the virus is impacting cancer patients in the United States is available here: https://www.cancertodaymag.org/Pages/cancer-talk/The-Coronavirus-and-Cancer-Care.aspx.
Additional resources for patients and families are available below:
- A preliminary analysis of 355 deaths from COVID-19 in Italy found that one in five were cancer patients, according to a report in The Cancer Letter, a weekly newsletter.
- The CDC has a webpage with information on “How to Protect Yourself” from COVID-19 infections.
- The NCI also has created a webpage for cancer patients and others titled Coronavirus: What People with Cancer Should Know.
- The FDA has taken steps to address the needs of patients, including those with cancer. The agency has allowed the expanded use of some non-invasive devices that can monitor the vital signs of patients remotely.